biOasis Technologies Ord Shs BIOAF

Primary Symbol: V.BTI.H

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > New Press Release - Canadian Investment Regulatory Organization Trading Halt - BTI

<< Previous

Bullboard Posts

Next >>

Comment by fuzzyjron Mar 22, 2024 6:19pm

118 Views

Post# 35948239

RE:RE:RE:RE:RE:New Press Release - Canadian Investment Regulatory Organization Trading Halt - BTI

Yes , I never like to give up on anything so maybe we see that rabbit out of a hat trick - would be nice for so many. I know once or if ever the rvx or zenith stories clear up or end I'll never touch a biotech play again in my life!!
Its a shrewd game & takes no prisoners! Always filled with so much hope & as we've learned the hard way can come with much dispair & sadness.

chin up buddy , we still have lots to be grateful for.

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale